Trademark: 85202806
Word
EPIGENE.COM
Status
Dead
Status Code
606
Status Date
Monday, February 13, 2012
Serial Number
85202806
Mark Type
4000
Filing Date
Tuesday, December 21, 2010
Published for Opposition
Tuesday, May 17, 2011
Abandoned Date
Monday, February 13, 2012

Trademark Owner History
Epigenesis Pharmaceuticals, LLC - Owner At Publication

Classifications
5 medical diagnostic and therapeutic preparations, all for administration via diverse routes of administration including through the respiratory airways, and, medical devices for administering the pharmaceuticals, sold filled, the preparations including nucleotides, proteins and organic molecules for medical use, including macromolecules such as anti-sense oligonucleotides and enzymes and small and inorganic molecules for treatment of human and non-human animal respiratory, central nervous system, neoplastic, endocrine, immune and cardiovascular ailments, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, which in some cases are adenosine receptor associated symptoms; pharmaceutical preparations for testing, and preventing and therapeutically treating respiratory, airway and pulmonary diseases and conditions, such as asthma, pulmonary vasoconstriction, inflammation, allergies, impeded respiration, acute respiratory disease syndrome (ards), renal damage and failure, ischemia resulting from the administration of certain drugs, including adenosine and other drugs for, for example, treating supra ventricular tachycardia (svt), adenosine stress tests, infantile respiratory distress syndrome (infantile rds), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasconcontriction, emphysema, chronic obstructive pulmonary disease (copd), as well as cancers including leukemias, lymphomas, carcinomas, and the like, e.g., colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, etc, as well as metastatic cancers, e.g., cancers which metastasized to the lung(s), breast, liver and prostate
EPIGENESIS

Trademark Events
Mar 9, 2012
Undeliverable Mail - No Action Taken
Feb 13, 2012
Abandonment Notice Mailed - No Use Statement Filed
Feb 13, 2012
Abandonment - No Use Statement Filed
Jul 26, 2011
Undeliverable Mail - No Action Taken
Jul 22, 2011
Undeliverable Mail - No Action Taken
Jul 12, 2011
Noa Mailed - Sou Required From Applicant
May 18, 2011
Notice Of Publication
May 17, 2011
Published For Opposition
May 5, 2011
Withdrawal Of Attorney Granted
May 5, 2011
Teas Withdrawal Of Attorney Received
Apr 9, 2011
Law Office Publication Review Completed
Apr 9, 2011
Assigned To Lie
Mar 29, 2011
Approved For Pub - Principal Register
Mar 29, 2011
Examiner's Amendment Entered
Mar 29, 2011
Notification Of Examiners Amendment E-Mailed
Mar 29, 2011
Examiners Amendment E-Mailed
Mar 29, 2011
Examiners Amendment -Written
Mar 21, 2011
Assigned To Examiner
Dec 31, 2010
Notice Of Pseudo Mark Mailed
Dec 30, 2010
New Application Office Supplied Data Entered In Tram
Dec 24, 2010
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24